Journal
ANNALS OF PHYSICAL AND REHABILITATION MEDICINE
Volume 66, Issue 1, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.rehab.2022.101682
Keywords
Outcome measures; IPF Sarcoidosis Scleroderma Pulmonary; rehabilitation; Exercise
Categories
Ask authors/readers for more resources
This study reviewed the effects of exercise-based interventions on individuals with ILD and summarized the ILD-specific outcome measures used in these interventions and their measurement properties. The findings indicated that ILD-specific outcome measures are infrequently used in exercise-based intervention trials, and there is limited information on their measurement properties.
Background: Effects of exercise-based interventions (EBIs) on people with interstitial lung disease (ILD) are not yet fully understood. Reasons may include the limited use of ILD-specific measures and/or the lack of adequate information regarding their measurement properties. The purpose of this review was to summarize the ILD-specific outcome measures used in EBI studies and their measurement properties. Methods: This was a two-phase systematic review: phase 1 identified ILD-specific measures used in EBI stud-ies; phase 2 reviewed their measurement properties. PubMed, Web of Science, Scopus, EBSCO and EMBASE were searched up to March 2021. One reviewer extracted data, and 2 reviewers independently assessed studies risk of bias as well as the quality of measurement properties using the Consensus-Based Standards for the Selection of Health Status Measurement Instruments (COSMIN) recommendations.Results: Phase 1 identified 18 records. The St George's Respiratory Questionnaire for Interstitial Pulmonary Fibrosis (SGRQ-IPF) was the only ILD-specific outcome measure used (n = 2 trials). Phase 2 resulted in 31 eli-gible records; measurement properties were reported for 12 measures. Measures presented sufficient con-tent validity, internal consistency (Cronbach's alpha 0.61-0.96), test-retest reliability (intraclass correlation coefficient 0.39; 0.96), hypothesis testing and responsiveness but were insufficient for measurement error and indeterminate for cross-cultural and structural validity. The outcome measures King's Brief Interstitial Lung Disease and SGRQ-IPF had higher evidence of adequate measurement properties than other measures. Quality of the evidence was mostly very low to moderate.Conclusions: ILD-specific outcome measures are used infrequently in EBI trials, and there is scarce informa-tion regarding their measurement properties. Database Registration: CRD42018112466 & COPY; 2022 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available